1. Nanjwade B.K., Bechra H.M., Derkar G.K., Manvi F.V., and
Nanjwade V.K., Dendrimers: Emerging Polymers for Drug-
Delivery Systems, Eur. J. Pharm. Sci., 38, 185-196, 2009.
2. Ghasemi S. and Ghezelsofloo M., Application of Polyurethane
in Drug Delivery System (Persian), Polymerization, 11, 31-38,
2022.
3. Nikzamir M., Hanifehpour Y., Akbarzadeh A., and Panahi
Y., Applications of Dendrimers in Nanomedicine and Drug
Delivery: A Review, J. Inorg. Organomet. Polym. Mater., 31,
2246-2261, 2021.
4. Garg T., Singh O., Arora S., and Murthy R., Dendrimer- A
Novel Scaffold for Drug Delivery, Int. J. Pharm. Sci. Rev.
Res., 7, 211-220, 2011.
5. Mignani S., El Kazzouli S., Bousmina M., and Majoral J.P.,
Expand Classical Drug Administration Ways by Emerging
Routes Using Dendrimer Drug Delivery Systems: A Concise
Overview, Adv. Drug Deliv. Rev., 65, 1316-1330, 2013.
6. Cheng Y., Xu Z., Ma M., and Xu T., Dendrimers as Drug Carri-
ers: Applications in Different Routes of Drug Administration,
J. Pharm. Sci., 97, 123-143, 2008.
7. Gebbia V. and Puozzo C., Oral Versus Intravenous Vinorelbine:
Clinical Safety Profile, Expert Opin. Drug. saf., 4, 915-928, 2005.
8. Caminade AM. and Turrin C.O., Dendrimers for Drug Delivery,
J. Mater. Chem. B, 2, 4055-4066, 2014.
9. Markman M., Intraperitoneal Antineoplastic Drug Delivery:
Rationale and Results, Lancet Oncol., 4, 277-283, 2003.
10. Roberts J.C., Bhalgat M.K., and Zera R.T., Preliminary Bio
logical Evaluation of Polyamidoamine (PAMAM) Starburst
Dendrimers, J. Biomed. Mater. Res., 30, 53-65, 1996.
11. Malik N., Evagorou E.G., and Duncan R., Dendrimer-Plati
nate: A Novel Approach to Cancer Chemotherapy, Anti-Can
cer Drug., 10, 767-776, 1999.
12. Chen H.T., Neerman M.F., Parrish A.R., and Simanek E.E.,
Cytotoxicity, Hemolysis, and Acute In Vivo Toxicity of Den
drimers Based on Melamine, Candidate Vehicles for Drug
Delivery, J. Am. Chem. Soc., 126, 10044-10048, 2004.
13. Padilla De Jesús O.L., Ihre H.R., Gagne L., Fréchet J.M., and
Szoka F.C., Polyester Dendritic Systems for Drug Delivery
Applications: In Vitro and In Vivo Evaluation, Bioconjugat
Chem., 13, 453-461, 2002.
14. Kukowska-Latallo J.F., Candido K.A., Cao Z., Nigavekar S.S.
Majoros I.J., Thomas T.P. et al., Nanoparticle Targeting of
Anticancer Drug Improves Therapeutic Response in Animal
Model of Human Epithelial Cancer, Cancer Res., 65, 5317
5324, 2005.
15. Malik N., Wiwattanapatapee R., Klopsch R., Lorenz K., Frey
H., Weener J.W. et al., Dendrimers: Relationship Between Structure and Biocompatibility in Vitro, and Preliminary Stud-
ies on the Biodistribution of 125I-labelled Polyamidoamine
Dendrimers In Vivo, J. Control. Release, 65, 133-148, 2000.
16. Wilbur D.S., Pathare P.M., Hamlin D.K., Buhler K.R., and
Vessella R.L., Biotin Reagents for Antibody Pretargeting. 3.
Synthesis, Radioiodination, and Evaluation of Biotinylated
Starburst Dendrimers, Bioconjugate Chem., 9, 813-825, 1998.
17. Moreno-Sastre M., Pastor M., Salomon C.J., Esquisabel A.,
and Pedraz J.L., Pulmonary Drug Delivery: A Review on
Nanocarriers for Antibacterial Chemotherapy, J. Antimicrob.
Chemother., 70, 2945-2955, 2015.
18. Bai S., Thomas C., and Ahsan F., Dendrimers as a Carrier for
Pulmonary Delivery of Enoxaparin, A Low-Molecular Weight
Heparin, J. Pharm. Sci., 96, 2090-2106, 2007.
19. Nasr M., Najlah M., D’Emanuele A., and Elhissi A., PAMAM
Dendrimers as Aerosol Drug Nanocarriers for Pulmonary
Deliveryvia Nebulization, Int. J. Pharm., 461, 242-250, 2014.
20. Kojima C., Kono K., Maruyama K., and Takagishi T., Syn-
thesis of Polyamidoamine Dendrimers Having Poly(ethylene
glycol) Grafts and their Ability to Encapsulate Anticancer
Drugs, Bioconjugate Chem., 11, 910-917, 2000.
21. Najlah M., Freeman S., Attwood D., and D’Emanuele A., Syn-
thesis, Characterization and Stability of Dendrimer Prodrugs,
Int. J. Pharm., 308, 175-182, 2006.
22. Sakthivel T., Toth I., and Florence A.T., Distribution of a Li-
pidic 2.5 nm Diameter Dendrimer Carrier After Oral Adminis-
tration, Int. J. Pharm., 183, 51-55, 1999.
23. Singh A.K., Sharma A.K., Kha I., Gothwal A., Gupta L., and
Gupta U., Oral Drug Delivery Potential of Dendrimers, in Nano-
structures for Oral Medicine, Elsevier Science, 231-261, 2017.
24. Ramachandran C. and Fleisher D., Transdermal Delivery of
Drugs for the Treatment of Bone Diseases, Adv. Drug Deliv.
Rev., 42, 197-223, 2000.
25. Thomas B.J. and Finnin B.C., The Transdermal Revolution,
Drug Discov., 9, 697-703, 2004.
26. Sun M., Fan A., Wang Z., and Zhao Y., Dendrimer-Mediated
Drug Delivery to the Skin, Soft Matter, 8, 4301-4305, 2012.
27. Wang Z., Itoh Y., Hosaka Y., Kobayashi I., Nakano Y., Maeda
I. et al., Novel Transdermal Drug Delivery System with Poly-
hydroxyalkanoate and Starburst Polyamidoamine Dendrimer,
J. Biosci. Bioeng., 95, 541-543, 2003.
28. Wang Z., Itoh Y., Hosaka Y., Kobayashi I., Nakano Y., Maeda
I. et al., Mechanism of Enhancement Effect of Dendrimer on
Transdermal Drug Permeation through Polyhydroxyalkanoate
Matrix, J. Biosci. Bioeng., 96, 537-540, 2003.
29. Geroski D.H. and Edelhauser H.F., Transscleral Drug Delivery
for Posterior Segment Disease, Adv. Drug Deliv. Rev., 52, 37-
48, 2001.
30. Souto E.B., Dias-Ferreira J., López-Machado A., Ettcheto M.,
Cano A., Camins Espuny A. et al., Advanced Formulation
Approaches for Ocular Drug Delivery: State-of-the-Art and
Recent Patents, Pharmaceutics, 11, 460, 2019.
31. Shimpi S., Chauhan B., and Shimpi P., Cyclodextrins:
Application in Different Routes of Drug Administration, Acta
Pharm., 55, 139-156, 2005.
32. Vandamme T.F. and Brobeck L., Poly(amidoamine) Den-
drimers as Ophthalmic Vehicles for Ocular Delivery of
Pilocarpine Nitrate and Tropicamide, J. Control Release, 102,
3-38, 2005.
33. Wiwattanapatapee R., Carreño-Gómez B., Malik N., and Dun-
can R., Anionic PAMAM Dendrimers Rapidly Cross Adult Rat
Intestine In Vitro: A Potential Oral Delivery System, Pharm.
Res., 17, 991-998, 2000.
34. Myles M.E., Neumann D.M., and Hill J.M., Recent Progress in
Ocular Drug Delivery for Posterior Segment Disease: Emphasis
on Transscleral Iontophoresis, Adv. Drug. Deliv. Rev., 57, 2063-
2079, 2005.
)